TARO-METHYLPREDNISOLONE INJECTION 40 MG
METHYLPREDNISOLONE ACETATE : 40 MG · DIN 02518120 · TARO PHARMACEUTICALS INC
Health Canada status: APPROVED
What is TARO-METHYLPREDNISOLONE INJECTION?
TARO-METHYLPREDNISOLONE INJECTION 40 MG contains METHYLPREDNISOLONE ACETATE : 40 MG. It is listed in the Health Canada Drug Product Database under DIN 02518120, held by TARO PHARMACEUTICALS INC, supplied as SUSPENSION for INTRA-ARTICULAR ; INTRALESIONAL ; INTRASYNOVIAL ; INTRAMUSCULAR administration. Health Canada currently lists it as approved, status dated 15-Jul-2021. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02518120 |
|---|---|
| Brand name | TARO-METHYLPREDNISOLONE INJECTION |
| Generic / active ingredient | METHYLPREDNISOLONE ACETATE : 40 MG |
| Manufacturer | TARO PHARMACEUTICALS INC |
| Strength | 40 MG |
| Dosage form | SUSPENSION |
| Route of administration | INTRA-ARTICULAR ; INTRALESIONAL ; INTRASYNOVIAL ; INTRAMUSCULAR |
| Schedule | Prescription |
| ATC code | H02AB04 METHYLPREDNISOLONE |
| AHFS class | 84:80.00 |
| Biosimilar | No |
| Health Canada status | APPROVED |
| Status date | 15-Jul-2021 |
| Original market date | 2022-01-11 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code H02AB04 METHYLPREDNISOLONE. 13 of 34 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| DEPO-MEDROL | 20 MG | SUSPENSION | PFIZER CANADA ULC | MARKETED | DIN 01934325 |
| DEPO-MEDROL | 40 MG | SUSPENSION | PFIZER CANADA ULC | MARKETED | DIN 00030759 |
| DEPO-MEDROL | 40 MG | SUSPENSION | PFIZER CANADA ULC | MARKETED | DIN 01934333 |
| DEPO-MEDROL | 80 MG | SUSPENSION | PFIZER CANADA ULC | MARKETED | DIN 00030767 |
| DEPO-MEDROL | 80 MG | SUSPENSION | PFIZER CANADA ULC | MARKETED | DIN 01934341 |
| MEDROL | 16 MG | TABLET | PFIZER CANADA ULC | MARKETED | DIN 00036129 |
| MEDROL | 4 MG | TABLET | PFIZER CANADA ULC | MARKETED | DIN 00030988 |
| SOLU-MEDROL | 1 G | KIT ; POWDER FOR SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 02367971 |
| SOLU-MEDROL | 1 G | POWDER FOR SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 00036137 |
| SOLU-MEDROL | 125 MG | POWDER FOR SOLUTION ; KIT | PFIZER CANADA ULC | MARKETED | DIN 02367955 |
Who else supplies METHYLPREDNISOLONE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. METHYLPREDNISOLONE appears in 18 registered pack listings across 4 markets, published on 4 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.